This review focuses on recent advances in the development and use of bioactive glass for
tissue engineering applications. Despite its inherent brittleness, bioactive glass has several …

Biomaterials and tissue engineering scaffolds play a central role to repair bone defects.
Although ceramic derivatives have been historically used to repair bone, hybrid materials …

Since the discovery of silicate bioactive glass (BG) by Larry Hench in 1969, different classes
of BGs have been researched over decades mainly for bone regeneration. More recently …

Bioactive borate glass has been recognized to have both hard and soft tissue repair and
regeneration capabilities through stimulating both osteogenesis and angiogenesis …

Recently, bioactive glass has shown an incredible potential to address the assortment of
chronic wounds including diabetic and venous ulcers. In this regard, the textural properties …

Infection is a leading cause of total joint arthroplasty failure. Current preventative measures
incorporate antibiotics into the poly (methyl methacrylate)(PMMA) bone cement that anchors …

Abstract In 2014–2015, 61,421 total knee arthroplasties (TKAs) were performed in Canada;
an increase of about 20% over 2000–2001. Revision total knee arthroplasties (rTKAs) …

Wollastonite (CaSiO3) and diopside (CaMgSi2O6) silicate ceramics have been widely
investigated as highly bioactive materials, suitable for bone tissue engineering applications …

Bioactive glasses were discovered in 1969 and provided for the first time an alternative to
nearly inert implant materials. They formed a rapid, strong, and stable bond with host …

A titanium-containing borate glass series based on the system (52-X) B 2 O 3–12CaO–6P 2
O 5–14Na 2 O–16ZnO-XTiO 2 with X varying from 0, 5 and 15 mol% of TiO 2 incorporated …